» Articles » PMID: 35726088

Structure of Human NTCP Reveals the Basis of Recognition and Sodium-driven Transport of Bile Salts into the Liver

Overview
Journal Cell Res
Specialty Cell Biology
Date 2022 Jun 21
PMID 35726088
Authors
Affiliations
Soon will be listed here.
Citing Articles

Hepatitis B and D virus entry.

Watashi K, Shionoya K, Kobayashi C, Morita T Nat Rev Microbiol. 2024; .

PMID: 39572840 DOI: 10.1038/s41579-024-01121-2.


The Culprit Behind HBV-Infected Hepatocytes: NTCP.

Li S, Hao L, Deng J, Zhang J, Yu F, Ye F Drug Des Devel Ther. 2024; 18:4839-4858.

PMID: 39494152 PMC: 11529284. DOI: 10.2147/DDDT.S480151.


Structural basis for hepatitis B virus restriction by a viral receptor homologue.

Shionoya K, Park J, Ekimoto T, Takeuchi J, Mifune J, Morita T Nat Commun. 2024; 15(1):9241.

PMID: 39455604 PMC: 11511851. DOI: 10.1038/s41467-024-53533-6.


Targeting NTCP for liver disease treatment: A promising strategy.

Tan X, Xiang Y, Shi J, Chen L, Yu D J Pharm Anal. 2024; 14(9):100979.

PMID: 39310850 PMC: 11415714. DOI: 10.1016/j.jpha.2024.100979.


Transporter Proteins as Therapeutic Drug Targets-With a Focus on SGLT2 Inhibitors.

Komaniecka N, Maroszek S, Drozdzik M, Oswald S, Drozdzik M Int J Mol Sci. 2024; 25(13).

PMID: 39000033 PMC: 11241231. DOI: 10.3390/ijms25136926.


References
1.
Jani M, Beery E, Heslop T, Toth B, Jagota B, Kis E . Kinetic characterization of bile salt transport by human NTCP (SLC10A1). Toxicol In Vitro. 2017; 46:189-193. DOI: 10.1016/j.tiv.2017.10.012. View

2.
Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z . Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012; 1:e00049. PMC: 3485615. DOI: 10.7554/eLife.00049. View

3.
Bae M, Cassilly C, Liu X, Park S, Tusi B, Chen X . Akkermansia muciniphila phospholipid induces homeostatic immune responses. Nature. 2022; 608(7921):168-173. PMC: 9328018. DOI: 10.1038/s41586-022-04985-7. View

4.
Lowjaga K, Kirstgen M, Muller S, Goldmann N, Lehmann F, Glebe D . Long-term -inhibition of the hepatitis B and D virus receptor NTCP by taurolithocholic acid. Am J Physiol Gastrointest Liver Physiol. 2020; 320(1):G66-G80. DOI: 10.1152/ajpgi.00263.2020. View

5.
Urban S, Bartenschlager R, Kubitz R, Zoulim F . Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology. 2014; 147(1):48-64. DOI: 10.1053/j.gastro.2014.04.030. View